PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Diabetes & Metabolism Journal10.4093/dmj.2020.00572021454505-514Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes MellitusJa Young Jeon, Kyoung Hwa Ha, Dae Jung Kimhttp://www.e-dmj.org/upload/pdf/dmj-2020-0057.pdf, http://www.e-dmj.org/journal/view.php?doi=10.4093/dmj.2020.0057, http://e-dmj.org/upload/pdf/dmj-2020-0057.pdf
Diabetes, Obesity and Metabolism10.1111/dom.130472017201113-120Efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors as monotherapy or add‐on to metformin in patients with type 2 diabetes mellitus: A systematic review and meta‐analysisZhiying Wang, Jiahui Sun, Ruobing Han, Dongzhu Fan, Xinyi Dong, Zenghui Luan, Rongwu Xiang, Mingyi Zhao, Jingyu Yanghttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.13047, https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13047, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/dom.13047, https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13047
Diabetes10.2337/db19-160-lb201968Supplement_1160-LB: Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Hemodynamic and Metabolic Cardiovascular Markers in Patients with Type 2 Diabetes MellitusNATTAPOL SATHAVARODOMhttps://diabetesjournals.org/diabetes/article/68/Supplement_1/160-LB/59609/160-LB-Effect-of-Sodium-Glucose-Cotransporter-2, https://diabetesjournals.org/diabetes/article/68/Supplement_1/160-LB/59609/160-LB-Effect-of-Sodium-Glucose-Cotransporter-2
Diabetes10.2337/db22-125-lb202271Supplement_1125-LB: Individualized Cost-Effectiveness Assessment of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) vs. Sulfonylureas as Add-On Therapy in People with Inadequately Controlled Type 2 Diabetes (T2D) Under Metformin MonotherapyDAWEI GUAN, SHU NIU, VIVIAN FONSECA, LIZHENG SHI, NEDA LAITEERAPONG, JINGCHUAN GUO, HUI SHAOhttps://diabetesjournals.org/diabetes/article/71/Supplement_1/125-LB/145636/125-LB-Individualized-Cost-Effectiveness, https://diabetesjournals.org/diabetes/article/71/Supplement_1/125-LB/145636/125-LB-Individualized-Cost-Effectiveness
Diabetes/Metabolism Research and Reviews10.1002/dmrr.24942014304269-283The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysisPaweł Kawalec, Alicja Mikrut, Sylwia Łopuchhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdmrr.2494, http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.2494/fullpdf
Value in Health10.1016/j.jval.2016.09.18342016197A665An Assessment of The Relative Efficacy of Sodium Glucose Co-Transporter 2 Inhibitors As Add-On To Metformin In Patients With Type 2 Diabetes MellitusC Whittington, A Schubert, C Neslusanhttps://api.elsevier.com/content/article/PII:S1098301516332004?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301516332004?httpAccept=text/plain
Revista Clínica Española (English Edition)10.1016/j.rceng.2019.09.0112020220124-26Metformin and sodium-glucose cotransporter inhibitors as therapy for type 1 diabetes mellitus: Handle with careJ. Ena, R. Gómez-Huelgashttps://api.elsevier.com/content/article/PII:S2254887419302589?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2254887419302589?httpAccept=text/plain
The Diabetes Educator10.1177/01457217156076432015411_suppl5S-18SSodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes MellitusEva Vivianhttp://journals.sagepub.com/doi/pdf/10.1177/0145721715607643, http://journals.sagepub.com/doi/full-xml/10.1177/0145721715607643, http://journals.sagepub.com/doi/pdf/10.1177/0145721715607643
Diabetes, Obesity and Metabolism10.1111/dom.13477201821128-36Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetesGhadeer K. Dawwas, Steven M. Smith, Haesuk Parkhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.13477, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13477/fullpdf
Value in Health10.1016/j.jval.2019.09.2750201922121458-1469Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-AnalysisBhavani Shankara Bagepally, Yogesh Krishnarao Gurav, Thunyarat Anothaisintawee, Sitaporn Youngkong, Usa Chaikledkaew, Ammarin Thakkinstianhttps://api.elsevier.com/content/article/PII:S1098301519351320?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301519351320?httpAccept=text/plain